🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for Systemic Lupus Erthematosus (SLE)

2-HOBA in Systemic Lupus Erythematosus NCT07225543Phase 21 site📍 Nashville Vanderbilt University Medical Center · Tests: 2-HOBA acetate (2-Hydroxybenzlamine acetate), Placebo CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease NCT07305116Phase 11 site📍 Hangzhou The Children's Hospital of Zhejiang University School of Me… · Tests: UCAR T-cell Effect of Anti-inflammatory Diet in Systemic Lupus Erythematous NCT07713940NA1 site📍 La Jolla University of California, San Diego · Tests: anti-inflammatory diet UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients NCT06737380Phase 11 site📍 Charleston LiveKidney.Bio · Tests: Physical examination, Electrocardiogram, SF-36 questionnaire, Clinical laboratory evaluations - Serology, Clinical labo… A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE) NCT07564596Phase 1, Phase 210 sites📍 Mianyang📍 Baoji📍 Beijing Climb Bio, Inc. · Tests: Budoprutug The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions NCT07278609n/a1 site📍 Montreal McGill University Health Centre/Research Institute of the M… · Tests: MedSafer deprescribing opportunity reports, EMPOWER brochures Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease NCT07507201EARLY Phase 11 site📍 Hangzhou The Children's Hospital of Zhejiang University School of Me… · Tests: UCAR T-cell A Study of GR1803 in Systemic Lupus Erythematosus NCT07348055Phase 1, Phase 21 site📍 Wuhan Genrix (Shanghai) Biopharmaceutical Co., Ltd. · Tests: GR1803 injection CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease NCT07586267EARLY Phase 11 site📍 Hangzhou The Children's Hospital of Zhejiang University School of Me… · Tests: QT-219CX A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) NCT07491900Phase 11 site📍 Brisbane Hinge Bio · Tests: HB2198 Safety, Pharmacokinetics, Immunogenicity BCD-256-1 and Divozilimab in Subjects With Systemic Lupus Erythematosus NCT07136389Phase 11 site📍 Saint Petersburg Biocad · Tests: BCD-256, BCD-256, BCD-256, Divozilimab, BCD-256 Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy NCT07150000n/a1 site📍 Bonn University of Bonn · Tests: Ex Vivo Assay
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy